Clinical impact of perirenal thickness on short- and long-term outcomes of gastric cancer after curative surgery.
gastric cancer
perirenal fat
predictive marker
short‐ and long‐term outcomes
Journal
Annals of gastroenterological surgery
ISSN: 2475-0328
Titre abrégé: Ann Gastroenterol Surg
Pays: Japan
ID NLM: 101718062
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
09
09
2021
revised:
18
12
2021
accepted:
02
01
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
A variety of factors for short- and long-term outcomes have been reported after radical resection for gastric cancer (GC). Obesity and emaciation had been reported to be a cause of poor short- and long-term outcomes with gastrointestinal cancer. However, the indicators are still controversial. The purpose of this study was to evaluate the relationship between perirenal thickness (PT) and short- and long-term outcomes after radical surgery for GC. We analyzed the data of 364 patients with GC who underwent radical surgery. We evaluated the distance from the anterior margin of the quadratus lumborum muscle to the dorsal margin of the left renal pole using computed tomography (CT) as an indicator of PT. The association between PT and clinicopathological factors and short- and long-term outcomes was evaluated. The PT data were divided into low, normal, and high groups by gender using the tertile value. We found that the PT low group was 121 patients, normal group was 121 patients, and high group was 122 patients. Multivariate analyses showed that the high PT group was an independent risk factor for a short-outcome after curative surgery in GC patients (odds ratio 2.163; 95% confidence interval [CI] 1.156-4.046; Perirenal thickness is a simple and useful factor for predicting short- and long-term outcomes after radical surgery for GC.
Sections du résumé
Background
UNASSIGNED
A variety of factors for short- and long-term outcomes have been reported after radical resection for gastric cancer (GC). Obesity and emaciation had been reported to be a cause of poor short- and long-term outcomes with gastrointestinal cancer. However, the indicators are still controversial. The purpose of this study was to evaluate the relationship between perirenal thickness (PT) and short- and long-term outcomes after radical surgery for GC.
Methods
UNASSIGNED
We analyzed the data of 364 patients with GC who underwent radical surgery. We evaluated the distance from the anterior margin of the quadratus lumborum muscle to the dorsal margin of the left renal pole using computed tomography (CT) as an indicator of PT. The association between PT and clinicopathological factors and short- and long-term outcomes was evaluated.
Results
UNASSIGNED
The PT data were divided into low, normal, and high groups by gender using the tertile value. We found that the PT low group was 121 patients, normal group was 121 patients, and high group was 122 patients. Multivariate analyses showed that the high PT group was an independent risk factor for a short-outcome after curative surgery in GC patients (odds ratio 2.163; 95% confidence interval [CI] 1.156-4.046;
Conclusion
UNASSIGNED
Perirenal thickness is a simple and useful factor for predicting short- and long-term outcomes after radical surgery for GC.
Identifiants
pubmed: 35847439
doi: 10.1002/ags3.12547
pii: AGS312547
pmc: PMC9271023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
496-504Informations de copyright
© 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology.
Références
Surg Endosc. 2009 Sep;23(9):2085-93
pubmed: 19116746
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):433-42
pubmed: 17563461
Surg Endosc. 2009 Jul;23(7):1460-4
pubmed: 19116737
Ann Surg Oncol. 2014 Jun;21(6):2044-50
pubmed: 24671637
Eur J Surg Oncol. 2018 Dec;44(12):1971-1981
pubmed: 30348605
J Surg Oncol. 2014 May;109(6):586-92
pubmed: 24374857
J Clin Oncol. 2004 Jul 15;22(14):2767-73
pubmed: 15199090
BJS Open. 2020 Oct;4(5):865-872
pubmed: 32893991
World J Surg Oncol. 2019 Mar 18;17(1):52
pubmed: 30885211
Ann Surg Oncol. 2015 Nov;22(12):3946-53
pubmed: 25712800
Ann Surg Oncol. 2013 May;20(5):1575-83
pubmed: 23076557
Br J Surg. 2005 Sep;92(9):1103-9
pubmed: 16106493
Ann Surg Oncol. 2014 Mar;21(3):891-8
pubmed: 24254205
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
World J Surg. 2009 Sep;33(9):1889-94
pubmed: 19603227
World J Surg. 2021 Mar;45(3):815-821
pubmed: 33179125
Ann Surg Oncol. 2013 Mar;20(3):780-7
pubmed: 22976377
Hepatogastroenterology. 2007 Jun;54(76):1142-5
pubmed: 17629057
Ann Surg. 2015 Jun;261(6):1173-83
pubmed: 24950264
Br J Surg. 2014 Nov;101(12):1499-508
pubmed: 25132117
Surg Endosc. 2018 Jan;32(1):358-366
pubmed: 28656334
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Ann Surg Oncol. 2015 Dec;22(13):4432-7
pubmed: 25862583
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Surg Today. 2021 Jul;51(7):1169-1178
pubmed: 33693964
Eur J Clin Nutr. 2018 Mar;72(3):436-445
pubmed: 29184135